Abstract
Sterile alpha motif- and histidine/aspartic acid domain-containing protein 1 (SAMHD1) limits HIV-1 replication by hydrolyzing deoxynucleoside triphosphates (dNTPs) necessary for reverse transcription. Nucleoside reverse transcriptase inhibitors (NRTIs) are components of anti-HIV therapies. We report here that SAMHD1 cleaves NRTI triphosphates (TPs) at significantly lower rates than dNTPs and that SAMHD1 depletion from monocytic cells affects the susceptibility of HIV-1 infections to NRTIs in complex ways that depend not only on the relative changes in dNTP and NRTI-TP concentrations but also on the NRTI activation pathways. Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Cite
CITATION STYLE
Huber, A. D., Michailidis, E., Schultz, M. L., Ong, Y. T., Bloch, N., Puray-Chavez, M. N., … Sarafianos, S. G. (2014). SAMHD1 has differential impact on the efficacies of HIV nucleoside reverse transcriptase inhibitors. Antimicrobial Agents and Chemotherapy, 58(8), 4915–4919. https://doi.org/10.1128/AAC.02745-14
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.